Informations techniques
Exploitant
Winthrop médicaments (Groupe Sanofi Aventis)
Présentation
DILRENE LP 300 mg, gélule à libération prolongée
B/ 28 - (Code CIP : 331 991-4)
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
JJz2QCJ9vmKYaNaj